Mettler Toledo key statistics and ratios
In fiscal 2025, Mettler Toledo had a net margin of 21.6% and a current ratio of 1.14. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 51.4% | 52.7% | 52.8% | 53.0% | 53.9% | 54.7% | 56.4% | 57.3% | 57.8% | 57.4% | 57.9% | 58.4% | 58.4% | 58.9% | 59.2% | 60.1% | 59.4% | 60.3% |
| Net margin | 10.0% | 11.8% | 11.7% | 12.4% | 12.9% | 13.6% | 14.7% | 15.3% | 13.8% | 17.5% | 18.6% | 19.5% | 20.7% | 22.3% | 20.8% | 22.3% | 21.6% | 21.9% |
| Free-cash-flow margin | 10.0% | 9.9% | 7.9% | 9.9% | 11.1% | 13.3% | 14.9% | 13.4% | 14.3% | 14.4% | 16.8% | 20.5% | 21.6% | 18.8% | 22.7% | 22.3% | 21.1% | 20.9% |
| Return on equity | 24.3% | 31.3% | 34.7% | 36.2% | 34.7% | 40.9% | 54.3% | 75.7% | 76.6% | 90.1% | 111.0% | 171.4% | — | — | — | — | — | — |
| Return on assets | 10.0% | 11.6% | 12.3% | 14.1% | 14.7% | 16.4% | 17.9% | 18.6% | 15.9% | 19.8% | 20.8% | 21.5% | 25.0% | 25.6% | 23.0% | 26.2% | 25.0% | 24.5% |
| Asset turnover | 1.01 | 0.98 | 1.05 | 1.13 | 1.14 | 1.20 | 1.22 | 1.22 | 1.16 | 1.14 | 1.11 | 1.10 | 1.21 | 1.15 | 1.11 | 1.17 | 1.16 | 1.12 |
| Current ratio | 1.31 | 2.11 | 1.67 | 1.54 | 1.62 | 1.25 | 1.42 | 1.53 | 1.46 | 1.42 | 1.47 | 1.26 | 1.11 | 1.20 | 1.04 | 1.02 | 1.14 | 1.12 |
| Debt to equity | 28.6% | 88.3% | 64.7% | 47.0% | 44.2% | 62.8% | 101.6% | 205.6% | 179.0% | 175.4% | 306.9% | 472.1% | 981.2% | >999% | — | — | — | >999% |
| Effective tax rate | 23.2% | 24.5% | 22.8% | 24.0% | 24.0% | 24.0% | 23.9% | 23.8% | 34.5% | 21.4% | 17.7% | 19.5% | 19.0% | 18.5% | 19.0% | 16.8% | 17.1% | 17.5% |
| R&D as % of revenue | 5.2% | 4.9% | 5.0% | 4.8% | 4.9% | 5.0% | 5.0% | 4.8% | 4.7% | 4.8% | 4.8% | 4.5% | 4.6% | 4.5% | 4.9% | 4.9% | 5.0% | 5.0% |
| SG&A as % of revenue | 29.2% | 29.9% | 30.5% | 29.2% | 29.1% | 29.3% | 29.3% | 29.7% | 29.2% | 27.7% | 27.2% | 26.6% | 25.4% | 23.9% | 23.9% | 24.2% | 24.8% | 24.9% |
| Capital spending as % of revenue | 3.5% | 3.8% | 4.3% | 4.1% | 3.5% | 3.6% | 3.4% | 4.9% | 4.7% | 4.9% | 3.2% | 3.0% | 2.9% | 3.1% | 2.8% | 2.7% | 2.7% | 2.7% |
| Free cash flow ÷ net income | 100.0% | 83.7% | 67.7% | 79.8% | 86.1% | 97.4% | 101.3% | 87.6% | 103.4% | 82.4% | 90.2% | 104.9% | 104.2% | 84.6% | 109.1% | 100.2% | 97.6% | 95.4% |
| Dividends and buybacks ÷ free cash flow | 3.5% | 123.5% | 112.2% | 120.1% | 111.9% | 125.6% | 138.5% | 148.5% | 102.9% | 112.5% | 153.1% | 122.6% | 124.8% | 149.1% | 104.6% | 98.3% | 94.3% | 89.7% |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 60.0% | 61.2% | 59.5% | 59.0% | 59.2% | 59.8% | 58.7% | 63.3% |
| Net margin | 22.2% | 24.1% | 18.5% | 20.6% | 21.1% | 25.3% | 17.9% | 22.7% |
| Free-cash-flow margin | 24.4% | 21.5% | 20.1% | 21.6% | 26.7% | 16.3% | 12.9% | 27.5% |
| Current ratio | 1.01 | 1.02 | 1.01 | 1.12 | 1.07 | 1.14 | 1.20 | 1.12 |
| Debt to equity | — | — | — | — | — | — | — | >999% |
| R&D as % of revenue | 4.9% | 4.8% | 5.2% | 5.0% | 5.0% | 4.7% | 5.4% | 5.2% |
| SG&A as % of revenue | 24.0% | 22.7% | 27.5% | 25.2% | 24.1% | 23.0% | 27.3% | 25.6% |
Financial health
- Short-term assets cover short-term liabilities $1.3bn of assets due within a year against $1.2bn of liabilities due within a year.
- Short-term assets cover long-term liabilities $1.3bn short-term assets against $2.5bn of longer-dated liabilities.
- More cash than debt $51m of cash against $2.1bn of debt.
- Debt below 40% of shareholders' equity Debt is 16470% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 922% to 16470% over five years.
- A year's operating cash flow covers at least 20% of debt $975m of operating cash flow against $2.1bn of debt.
- Operating profit covers interest at least five times over Interest not separately reported. Not assessable.
Moat
Strong moat
How hard Mettler Toledo's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 20 / 20
Cash operating profit has been a median 34.5% of total assets over 10 years.
- Pricing power 20 / 20
Gross margin has been a median 58.5%, moving by 0.9 percentage points (standard deviation) across 10 years.
- Durability 16 / 20
Net margin has been a median 19.2%; its worst year was 13.5%.
- Cash conversion 20 / 20
Free cash flow was positive in 10 of 10 years, at a median 19.6% of revenue.
- Discipline 20 / 20
The diluted share count fell 14.6% over five years; stock-based pay has been a median 0.6% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (95 before it).
Compare with peers
- Charles River Laboratories statistics
- Illumina, Inc. statistics
- Waters Corporation statistics
- Bruker Corp statistics
- Medpace Holdings, Inc. statistics
Head to head: CRL vs MTDILMN vs MTDMTD vs WATBRKR vs MTD
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies